Co-Diagnostics, Inc. Common Stock (CODX) is a Healthcare · Medical Devices company listed on NASDAQ. Price $0.95 (+0.57%), Market cap $0.00B, 52-week low–high $0.17 ~ $6.19.
Co-Diagnostics, Inc. operates as a molecular diagnostics company that develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally. It offers Co-Dx PCR platform, a polymerase chain reaction testing to patients in point-of-care and at-home setting. The company also provides PCR diagnostic tests for COVID-19, influenza, tuberculosis, hepatitis B and C, malaria, dengue, human papillomavirus, chikungunya, and Zika virus. In addition, the company offers three multiplexed tests to test mosquitos for the identification of diseases carried by the mosquitos; molecular tools f
Financial statements, price targets, institutional (13F) holdings and related news for Co-Diagnostics, Inc. Common Stock are updated in real time on BlackAll Trade.
Co-Diagnostics, Inc. Common Stock trades at $0.95 (+0.57%). Real-time quotes and charts are available on BlackAll Trade.
Co-Diagnostics, Inc. Common Stock has a market cap of about $0.00B.
Co-Diagnostics, Inc. operates as a molecular diagnostics company that develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nuclei